Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers

Masaya Imoto

doi:10.1038/ja.2017.139

Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers

J Antibiot (Tokyo). 2017 Nov 1. doi: 10.1038/ja.2017.139. Online ahead of print.

Author

Masaya Imoto¹

Affiliation

¹ Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, Japan.

PMID: 29089596
DOI: 10.1038/ja.2017.139

Abstract

This issue is dedicated to Prof Hamao Umezawa in appreciation of his great contributions to pioneering research on antibiotics targeting oncogenes.The Journal of Antibiotics advance online publication, 1 November 2017; doi:10.1038/ja.2017.139.

Publication types

Review